(23-May-2005) Microtek International Inc. is pleased to announce the full licensure of Advantigen^TM 5.1, a pentavalent vaccine developed by Microtek Research and Development Ltd.

(30-September-2004) Microtek International Inc. is pleased to announce the introduction in Chile of Bayovac^® SRS, a recombinant vaccine against Piscirickettssia salmonis, developed by Microtek Research and Development Ltd.